全文获取类型
收费全文 | 336573篇 |
免费 | 22276篇 |
国内免费 | 7381篇 |
专业分类
耳鼻咽喉 | 4056篇 |
儿科学 | 9525篇 |
妇产科学 | 6543篇 |
基础医学 | 27386篇 |
口腔科学 | 7923篇 |
临床医学 | 36895篇 |
内科学 | 42161篇 |
皮肤病学 | 4558篇 |
神经病学 | 19247篇 |
特种医学 | 7799篇 |
外国民族医学 | 31篇 |
外科学 | 36196篇 |
综合类 | 50365篇 |
现状与发展 | 12篇 |
一般理论 | 29篇 |
预防医学 | 34189篇 |
眼科学 | 5257篇 |
药学 | 29892篇 |
371篇 | |
中国医学 | 30405篇 |
肿瘤学 | 13390篇 |
出版年
2023年 | 5230篇 |
2022年 | 9045篇 |
2021年 | 13033篇 |
2020年 | 12098篇 |
2019年 | 18010篇 |
2018年 | 15714篇 |
2017年 | 12603篇 |
2016年 | 10118篇 |
2015年 | 9444篇 |
2014年 | 19530篇 |
2013年 | 21062篇 |
2012年 | 17971篇 |
2011年 | 19463篇 |
2010年 | 15625篇 |
2009年 | 14334篇 |
2008年 | 13978篇 |
2007年 | 14471篇 |
2006年 | 12614篇 |
2005年 | 10962篇 |
2004年 | 8925篇 |
2003年 | 7850篇 |
2002年 | 6137篇 |
2001年 | 5534篇 |
2000年 | 4573篇 |
1999年 | 3974篇 |
1998年 | 3219篇 |
1997年 | 3078篇 |
1996年 | 2666篇 |
1995年 | 2567篇 |
1994年 | 2477篇 |
1993年 | 1972篇 |
1992年 | 2004篇 |
1991年 | 1728篇 |
1990年 | 1539篇 |
1989年 | 1370篇 |
1988年 | 1301篇 |
1987年 | 1120篇 |
1985年 | 3787篇 |
1984年 | 4796篇 |
1983年 | 3340篇 |
1982年 | 3805篇 |
1981年 | 3547篇 |
1980年 | 3159篇 |
1979年 | 2906篇 |
1978年 | 2536篇 |
1977年 | 1907篇 |
1976年 | 2150篇 |
1975年 | 1636篇 |
1974年 | 1433篇 |
1973年 | 1279篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
报告5例对胰岛素抵抗的糖尿病特殊类型病例,其均具有胰岛素应用指征,但使用胰岛素后血糖却反而上升,逐渐增加胰岛素用量,则血糖值亦呈上升趋势。对该类病人的治疗,首先停用胰岛素,改用自制中药制剂及优降糖、降糖灵治疗,取得了良好效果。 相似文献
992.
P. V. PEPLOW 《Medical education》1990,24(5):426-432
This paper reports an attempt to develop self-directed learning skills in second-year medical students by introducing case-based projects into the gross anatomy course at a long-established medical school. The programme and students' responses to a questionnaire completed at the end of the year are presented. Information on the various resources used by students to find information is given. The performance of students in the case-based components of the course has been evaluated and also in the more traditional end-of-year written examination. The data confirm that students have recognized that the projects were about obtaining a deeper understanding of the anatomy, and the programme appears to have promoted the use and study of library texts. 相似文献
993.
Polyclonal antibodies recognizing the pyridyloxobutyl (POB) moiety of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were produced in rabbits immunized either with POB-bovine albumin or POB-Sepharose. The POB intermediates necessary to modify the protein were generated by alkaline (pH 9.0) treatment of the synthetic precursor 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone. In a competitive enzyme linked immunoabsorbent assay (ELISA), 70 pmole NNK inhibited 50% of the binding of the anti-POB antibodies to POB-protein absorbed on microtiterplates. This 50% inhibition varied from 70 pmole to 200 nmole using a series of NNK analogues, depending on the integrity of the POB moiety. Immunological techniques initiated in this study detect NNK-protein conjugates or measure the quantity of POB groups liberated upon alkaline or acid treatment of NNK modified protein. 相似文献
994.
Julian J. Faraway 《Genetic epidemiology》1993,10(4):225-233
An improved sib-pair test for linkage is introduced which is superior to the previously proposed tests. The test is derived from the standard chi-squared goodness of fit statistic by restricting the alternative hypothesis to the genetically possible. Critical values are given and exact power comparisons are made with the previously proposed tests. The new test is shown to be more powerful for finite samples as well as being asymptotically uniformly most powerful. © 1993 Wiley-Liss, Inc. 相似文献
995.
保定地区1934年首次经血清学证实有EHF病例发生,并从疫区鼠类中查到EHF抗原,其阳性率分别为:褐家鼠4.85%,黑线姬鼠1.95%,大仓鼠0.79%,小家鼠0.51%,褐家鼠可能是我区的主要传染源。疫区健康人群血清EHF抗体阳性率为1.37%,女性显著高于男性。 相似文献
996.
The use of glutamate antagonists and GABA agonists may protect neurons from the effects of transient ischemia. Felbamate is a new antiepileptic drug with glutamate antagonist and GABA agonist properties, We tested the efficacy of felbamate in a gerbil model of transient forebrain ischemia. Damage assessment was done with silver staining at 7 and 28 days after 5 min of bilateral carotid occlusion, Cerebral cortex, hippocampus (CA1 and CA4), thalamus and striatum were evaluated on a 4-point scoring system, The animals sacrificed at 28 days were also tested in a water-maze task to assess recovery of function, The initial dose of felbamate (300 mg/kg) was given 30 min before the ischemic insult in one set of animals and 30 min after the insult in another set of animals. There were 8 animals tested per group (total: 48 animals). There was significant neuronal protection with the use of felbamate, both before and after ischemia in all regions of the brain. Protection was seen in animals sacrificed at 7 and 28 days, Protection was moderate when felbamate was used before ischemia. It was highly significant when felbamate was given 30 min after the insult. Behavioral studies however did not show any difference in the felbamate treated animals versus the saline treated controls. The structural protection with felbamate was very significant when used in the post-ischemic period. This window for protection merits further evaluation in relation to the clinical setting of stroke. 相似文献
997.
As part of a detailed study of limb defects and associated patterns of congenital malformations, cases with lower limb deficiencies were analysed separately. We identified a total of 130 cases with deficiencies of the lower limbs without defects of the upper limbs. This gives an incidence of 1.07/10,000 livebirths, or 1/9,337 for this group of limb defects. Most common were femur deficiencies and deficiencies of the foot. A preponderance of males was found in the group of transverse defects of the leg (fibula/tibia deficiencies) and central axis deficiencies, while females had significantly more often longitudinal tibia defects and preaxial ray defects. © 1993 Wiley-Liss, Inc. 相似文献
998.
利用特异性DNA倍增技术(polymerase chain Reaction,PCR)检测t-PA cDNA基因在表达细胞基因组中的稳定性,并对所得的PCR反应产物进行了限制性内切酶片段、分子杂交和核苷酸顺序分析等方面的研究,证实了t-PA cDNA基因已插入到表达细胞染色体中。这种方法快速、简便、灵敏度和特异性高,是检测基因工程表达细胞中cDNA基因稳定整合状况的好方法。 相似文献
999.
I. Wiklund F. Waagstein K. Swedberg Å. Hjalmarsson 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1996,10(3):361-368
Summary Quality of life in heart failure patients is receiving increased attention as a reflection of a treatment's potential secondary
benefit of general well-being and daily functioning. The Metoprolol in Dilated Cardiomyopathy (MDC) trial was conducted as
a large, multicenter trial to establish the effects of metoprolol on mortality and need for heart transplantation in patients
with symptomatic idiopathic cardiomyopathy. It was found that metoprolol was well tolerated, improved symptoms and cardiac
function, and prevented clinical deterioration in patients with symptomatic idiopathic dilated cardiomyopathy. Quality of
life was evaluated as a secondary endpoint in 345 out of 383 randomized patients using a disease-specific questionnaire, the
Quality of Life in Heart Failure Questionnaire, depicting physical activity, somatic symptoms, emotions, and life satisfaction.
In a comparison of patients treated with metoprolol or placebo, patients treated with metoprolol noted a significantly more
favorable response than those treated with placebo in terms of the overall treatment evaluation (p<0.05). Additionally, an
analysis of the changes from baseline to 18 months, using 95% confidence intervals, revealed that patients treated with metoprolol
showed a significant improvement from baseline to 18 months in life satisfaction, physical activity, and the total score,
while patients treated with placebo did not change at all. The improvement in quality of life was supported by the correlations
with improvement in traditional clinical parameters. 相似文献
1000.
In the last few years, survival of patients infected with human immunodeficiency virus (HIV) has been improved because of a decreased incidence of some opportunistic complications attributable to prophylactic treatments and antiretroviral drugs. The impact of these agents should also be reflected in the quality of life (QoL) of patients. We have reviewed this topic with an emphasis on different types of measurements such as Q-TWIST, MOS and the Spitzer score which seem to be most appropriate for this patient population. We do not think that a special type of assessment should be designed for HIV-infected persons. It would be less time-consuming to improve already existing validated scores focusing on HIV infection. QoL in intravenous drug users with HIV should be evaluated more often. 相似文献